Replimune Group Inc is listed on the CBOE trading with ticker code REPL.US. It has a market capitalisation of $828.54m, with approximately 83.95m shares in issue. Over the last year, Replimune Group ...
JFrog finds 148 npm proxy packages turned student browsers into a DDoS botnet, while a mutable loader lets operators re-arm ...
Millions of children will grab lunchboxes, backpacks and rolling bags and head to their first day of kindergarten this year. Some will go for a half day and some for a full. Some will attend private ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results